# Abstract CT281: A phase II trial of ivonescimab for previously treated thymic carcinoma UCLA L-11

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/abstract-ct281-a-phase-ii-trial-of-ivonescimab-for-previously-treated-thymic/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jonathan Boiarsky,Chi-hong Tseng,Zhaohui Arter,Matthew A. Gubens,Chul Kim,Jennifer A. Marks,Surbhi Singhal,Christine Kivork,Larissa Ikenouye,Jonathan W. Goldman |
| Citations | 0 |
| DOI | 10.1158/1538-7445.am2026-ct281 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W7154730863 |
| Type | conference-abstract |
| Year | 2026 |

## Paper authors

- [Jennifer A. Marks](https://scholariq.org/researchers/jennifer-a-marks/)

## Paper journal

- [Cancer Research](https://scholariq.org/journals/cancer-research/)

## Paper primary topic

- [Myasthenia Gravis and Thymoma](https://scholariq.org/topics/myasthenia-gravis-and-thymoma/)

## Paper topics

- [Myasthenia Gravis and Thymoma](https://scholariq.org/topics/myasthenia-gravis-and-thymoma/)
- [Cancer Research and Treatments](https://scholariq.org/topics/cancer-research-and-treatments/)
- [Cancer, Stress, Anesthesia, and Immune Response](https://scholariq.org/topics/cancer-stress-anesthesia-and-immune-response/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.